When Weed Is Banned, Delta-8 Steps Into The Gap For Millions

Where states ban marijuana, people are almost twice as likely to try delta-8. That is the headline finding from a nationally representative UC San Diego study in the American Journal of Preventive Medicine, which estimates more than 19 million U.S. adults have used the hemp-derived intoxicant at least once. The pattern is clear and a bit uncomfortable for lawmakers. When regulated cannabis is hard to get, a more lightly regulated substitute fills the shelf space.

Start with the numbers. Overall, 7.7 percent of U.S. adults reported lifetime delta-8 use, which scales to about 19.3 million people. In states that prohibit all marijuana use, the share jumps to 10.9 percent. In states with recreational legalization, it falls to 5.5 percent. Policy toward delta-8 itself matters too. Where delta-8 sales are unregulated, lifetime use is 10.5 percent. Where states regulate sales, use drops to 3.9 percent, and where states prohibit it, 4.5 percent. The adjusted models tug in the same direction, with a roughly 52 percent lower probability of delta-8 use in recreational states compared with prohibition states.

Turns out, people respond to access. Delta-8 occupies a legal gray space created after the 2018 Farm Bill legalized hemp with less than 0.3 percent delta-9 THC. Manufacturers can convert hemp cannabidiol into delta-8 through isomerization, then sell the result in vape shops, convenience stores, and online. Federal agencies have warned about safety and marketing to children, and the FDA says delta-8 is not a legal food additive, but enforcement has been piecemeal. Many states have not clarified anything. Markets hate a vacuum. So do entrepreneurs.

“These findings underscore that people don’t just stop using cannabis when their state bans it.”

That was Eric Leas, the study’s senior author and an assistant professor at UC San Diego. He adds that people often shift toward what is easy to get, even when that product is less studied or poorly regulated. The line has a familiar ring to anyone who has watched the nicotine market evolve from cigarettes to vapes to disposable synthetics. Close one door, another kiosk opens.

There is a buried lede here. The policy you choose for marijuana does not just affect marijuana. It shapes which intoxicants people try, and where they buy them. Regulated cannabis typically comes with potency caps, testing, labeling, and age checks. Delta-8 often does not. Some products are packaged to mimic snacks, which raises pediatric risk. The FDA has logged adverse events. Public health departments, already stretched, are left to explain that legal does not automatically mean safe.

“Providing legal access to cannabis that meets safety standards and disallowing understudied and poorly regulated products like delta-8 THC could be one way to prioritize public health in our cannabis policies.”

Leas is not subtle about the policy implications. If lawmakers want to reduce harms, the study suggests two levers that work in tandem. Expand access to tested, regulated cannabis, and close loopholes that enable loosely labeled substitutes to flourish. The adjusted risk ratios in the paper point in the same direction as the raw prevalence. Recreational laws are associated with less delta-8 experimentation. Regulations specific to delta-8 are associated with less use too.

And there is an economic angle that should not be ignored. Regulation pushes sales into licensed dispensaries and tax channels. Unregulated delta-8 pushes revenue into a diffuse supply chain that can outrun enforcement and data collection alike. If a state wants to understand who is consuming what, and how products are formulated, it helps when those products move through a system designed for transparency.

The study design has limits that the authors acknowledge. Self reporting is imperfect, policy categories can be contested, and cross sectional data do not prove causation. Enforcement also varies by state, sometimes by county. Still, the coherence of the pattern across multiple comparisons is hard to wave away. People substitute. Markets route around obstacles. Policymakers often play catch up.

So what to watch next. Congress is considering Farm Bill revisions that could cap total THC or restrict isomerized cannabinoids. States will likely keep experimenting with potency limits, retail rules, and age verification. The researchers say qualitative work is needed to understand why people choose delta-8, how they use it, and what experiences they have. In the meantime, the study doubles as a cautionary tale. Ban the thing you know, and you might boost the thing you do not.

Journal: American Journal of Preventive Medicine

DOI: 10.1016/j.amepre.2025.108026

Explainer: What Is Delta-8 THC, And Why Is It So Common?

Delta-8 THC is a psychoactive compound that can be made by converting hemp derived CBD. Hemp became legal to grow and sell under the 2018 Farm Bill if it contains no more than 0.3 percent delta-9 THC by dry weight. That opened a pathway for manufacturers to produce delta-8 and sell it outside state licensed cannabis systems. Because delta-8 often falls outside standard marijuana regulations, products can show up in vape shops, convenience stores, or online with limited testing, labeling, or age checks. Some states now ban or regulate delta-8 sales, others do not. The UC San Diego study finds that where marijuana is legal and where delta-8 is regulated, fewer adults report trying delta-8.